An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie ...

One dog, one vaccine, one data point. The story of Rosie is fascinating – but it is not yet evidence that AI can beat cancer.

Farmers' groups brought an urgent application calling for the unregulated procurement and administration of foot-and-mouth ...

Service members forced to leave the military for refusing to take the COVID-19 vaccine now have an extra year to return to ...

Pfizer Lyme vaccine candidate shows over 70% efficacy in phase 3 trial and moves forward with FDA regulatory submission.

Democratic lawmakers have long argued that expanding the state's authority over vaccine recommendations is needed amid major ...

In the latest survey of health policy experts conducted by the Cornell Health Policy Center, more than three-quarters of ...

Pulmonary expert Noah Greenspan, DPT, discusses long COVID, early pandemic uncertainty, and how vaccination may help reduce ...

(NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced topline results from the Phase 3 ...

The Metro Public Health Department said the bill could impact everything from wait times to vaccination rates.

The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% ...

University of Missouri researchers develop live HPAI vaccine with DIVA technology to distinguish vaccinated from infected birds, solving major poultry export barriers and reducing costs significantly.